Lupeng Pharmaceutical
广州麓鹏制药有限公司
Guangzhou, China · $35.0M raised
- Headquarters
- Guangzhou
- Business Model
- B2B
- Website
- lupengbio.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Venture RoundJan 2024
- Rounds
- 1
About
Chinese biotech developing small-molecule anti-tumor drugs and innovative oncology therapeutics including BTK inhibitors.
Summary
Lupeng Pharmaceutical is a Biotech company based in Guangzhou, China. It has raised $35.0M in total across 1 round, most recently a $35.0M Venture Round round in Jan 2024. Investors include Temasek, Kaitai Capital and Lilly Asia Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company